Loading...

Procter & Gamble Hygiene and Health Care

BSE:500459
Snowflake Description

Flawless balance sheet with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
500459
BSE
₹348B
Market Cap
  1. Home
  2. IN
  3. Household
Company description

Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast moving consumer goods in the femcare and healthcare businesses in India. The last earnings update was 71 days ago. More info.


Add to Portfolio Compare Print
500459 Share Price and Events
7 Day Returns
0.5%
BSE:500459
1.1%
IN Personal Products
1.1%
IN Market
1 Year Returns
10%
BSE:500459
1.5%
IN Personal Products
-0.9%
IN Market
500459 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Procter & Gamble Hygiene and Health Care (500459) 0.5% 4% 7.7% 10% 65.8% 215.6%
IN Personal Products 1.1% -0.6% -5.1% 1.5% 40.8% 143.3%
IN Market 1.1% 1.8% 5.7% -0.9% 41% 72.2%
1 Year Return vs Industry and Market
  • 500459 outperformed the Personal Products industry which returned 1.5% over the past year.
  • 500459 outperformed the Market in India which returned -0.9% over the past year.
Price Volatility
500459
Industry
5yr Volatility vs Market

500459 Value

 Is Procter & Gamble Hygiene and Health Care undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Procter & Gamble Hygiene and Health Care to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Procter & Gamble Hygiene and Health Care.

BSE:500459 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 2 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 14.4%
Perpetual Growth Rate 10-Year IN Government Bond Rate 7.6%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BSE:500459
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year IN Govt Bond Rate 7.6%
Equity Risk Premium S&P Global 8.6%
Personal Products Unlevered Beta Simply Wall St/ S&P Global 0.68
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.68 (1 + (1- 35%) (0%))
0.785
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.55% + (0.8 * 8.6%)
14.43%

Discounted Cash Flow Calculation for BSE:500459 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Procter & Gamble Hygiene and Health Care is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

BSE:500459 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (INR, Millions) Source Present Value
Discounted (@ 14.43%)
2019 6,438.00 Analyst x1 5,626.15
2020 5,692.00 Analyst x1 4,346.95
2021 7,510.00 Analyst x1 5,012.11
2022 7,264.98 Est @ -3.26% 4,237.16
2023 7,263.62 Est @ -0.02% 3,702.15
2024 7,427.19 Est @ 2.25% 3,308.15
2025 7,712.49 Est @ 3.84% 3,002.03
2026 8,094.56 Est @ 4.95% 2,753.43
2027 8,558.60 Est @ 5.73% 2,544.15
2028 9,095.90 Est @ 6.28% 2,362.91
Present value of next 10 years cash flows ₹36,895.19
BSE:500459 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= ₹9,095.90 × (1 + 7.55%) ÷ (14.43% – 7.55%)
₹142,189.53
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ₹142,189.53 ÷ (1 + 14.43%)10
₹36,937.60
BSE:500459 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ₹36,895.19 + ₹36,937.60
₹73,832.78
Equity Value per Share
(INR)
= Total value / Shares Outstanding
= ₹73,832.78 / 32.46
₹2274.53
BSE:500459 Discount to Share Price
Calculation Result
Value per share (INR) From above. ₹2,274.53
Current discount Discount to share price of ₹10,720.90
= -1 x (₹10,720.90 - ₹2,274.53) / ₹2,274.53
-371.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Procter & Gamble Hygiene and Health Care is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Procter & Gamble Hygiene and Health Care's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Procter & Gamble Hygiene and Health Care's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BSE:500459 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in INR ₹122.00
BSE:500459 Share Price ** BSE (2019-04-18) in INR ₹10720.9
India Personal Products Industry PE Ratio Median Figure of 17 Publicly-Listed Personal Products Companies 23.18x
India Market PE Ratio Median Figure of 2,736 Publicly-Listed Companies 16.34x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Procter & Gamble Hygiene and Health Care.

BSE:500459 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BSE:500459 Share Price ÷ EPS (both in INR)

= 10720.9 ÷ 122.00

87.88x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Procter & Gamble Hygiene and Health Care is overvalued based on earnings compared to the IN Personal Products industry average.
  • Procter & Gamble Hygiene and Health Care is overvalued based on earnings compared to the India market.
Price based on expected Growth
Does Procter & Gamble Hygiene and Health Care's expected growth come at a high price?
Raw Data
BSE:500459 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 87.88x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
20.8%per year
India Personal Products Industry PEG Ratio Median Figure of 7 Publicly-Listed Personal Products Companies 3.2x
India Market PEG Ratio Median Figure of 584 Publicly-Listed Companies 1.32x

*Line of best fit is calculated by linear regression .

BSE:500459 PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 87.88x ÷ 20.8%

4.22x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Procter & Gamble Hygiene and Health Care is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Procter & Gamble Hygiene and Health Care's assets?
Raw Data
BSE:500459 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in INR ₹282.91
BSE:500459 Share Price * BSE (2019-04-18) in INR ₹10720.9
India Personal Products Industry PB Ratio Median Figure of 20 Publicly-Listed Personal Products Companies 3.26x
India Market PB Ratio Median Figure of 3,627 Publicly-Listed Companies 1.11x
BSE:500459 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BSE:500459 Share Price ÷ Book Value per Share (both in INR)

= 10720.9 ÷ 282.91

37.9x

* Primary Listing of Procter & Gamble Hygiene and Health Care.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Procter & Gamble Hygiene and Health Care is overvalued based on assets compared to the IN Personal Products industry average.
X
Value checks
We assess Procter & Gamble Hygiene and Health Care's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Personal Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Personal Products industry average (and greater than 0)? (1 check)
  5. Procter & Gamble Hygiene and Health Care has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

500459 Future Performance

 How is Procter & Gamble Hygiene and Health Care expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
20.8%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Procter & Gamble Hygiene and Health Care expected to grow at an attractive rate?
  • Procter & Gamble Hygiene and Health Care's earnings growth is expected to exceed the low risk savings rate of 7.6%.
Growth vs Market Checks
  • Procter & Gamble Hygiene and Health Care's earnings growth is expected to exceed the India market average.
  • Procter & Gamble Hygiene and Health Care's revenue growth is positive but not above the India market average.
Annual Growth Rates Comparison
Raw Data
BSE:500459 Future Growth Rates Data Sources
Data Point Source Value (per year)
BSE:500459 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 20.8%
BSE:500459 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 4.5%
India Personal Products Industry Earnings Growth Rate Market Cap Weighted Average 14%
India Personal Products Industry Revenue Growth Rate Market Cap Weighted Average 10.8%
India Market Earnings Growth Rate Market Cap Weighted Average 18.6%
India Market Revenue Growth Rate Market Cap Weighted Average 11.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BSE:500459 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in INR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BSE:500459 Future Estimates Data
Date (Data in INR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-06-30 8,652 6,800
2020-06-30 28,703 6,792 4,879 1
2019-06-30 26,801 7,538 4,368 1
BSE:500459 Past Financials Data
Date (Data in INR Millions) Revenue Cash Flow Net Income *
2018-12-31 27,034 3,960
2018-09-30 25,895 4,031
2018-06-30 24,553 4,155 3,746
2018-03-31 24,335 4,081
2017-12-31 24,385 4,245
2017-09-30 23,776 4,439
2017-06-30 23,204 4,453 4,327
2017-03-31 25,574 4,647
2016-12-31 25,277 4,622
2016-09-30 25,433 4,581
2016-06-30 22,754 3,525 4,225
2016-03-31 24,823 4,209

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Procter & Gamble Hygiene and Health Care's earnings are expected to grow significantly at over 20% yearly.
  • Procter & Gamble Hygiene and Health Care's revenue is expected to grow by 4.5% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BSE:500459 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from Procter & Gamble Hygiene and Health Care Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BSE:500459 Future Estimates Data
Date (Data in INR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-06-30 209.90 209.90 209.90 1.00
2020-06-30 150.62 167.00 134.23 2.00
2019-06-30 134.40 134.40 134.40 1.00
BSE:500459 Past Financials Data
Date (Data in INR Millions) EPS *
2018-12-31 122.00
2018-09-30 124.20
2018-06-30 115.40
2018-03-31 125.72
2017-12-31 130.76
2017-09-30 136.74
2017-06-30 133.31
2017-03-31 143.17
2016-12-31 142.38
2016-09-30 141.11
2016-06-30 130.16
2016-03-31 129.66

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Procter & Gamble Hygiene and Health Care is expected to make outstanding use of shareholders’ funds in the future (Return on Equity greater than 40%).
X
Future performance checks
We assess Procter & Gamble Hygiene and Health Care's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Procter & Gamble Hygiene and Health Care has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

500459 Past Performance

  How has Procter & Gamble Hygiene and Health Care performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Procter & Gamble Hygiene and Health Care's growth in the last year to its industry (Personal Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Procter & Gamble Hygiene and Health Care's year on year earnings growth rate has been positive over the past 5 years.
  • Procter & Gamble Hygiene and Health Care's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Procter & Gamble Hygiene and Health Care's 1-year earnings growth is negative, it can't be compared to the IN Personal Products industry average.
Earnings and Revenue History
Procter & Gamble Hygiene and Health Care's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Procter & Gamble Hygiene and Health Care Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BSE:500459 Past Revenue, Cash Flow and Net Income Data
Date (Data in INR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 27,034.10 3,960.20 4,710.40
2018-09-30 25,895.00 4,031.40 4,409.50
2018-06-30 24,552.90 3,745.90 4,038.60
2018-03-31 24,335.10 4,080.80 3,389.90
2017-12-31 24,384.90 4,244.70 3,212.50
2017-09-30 23,775.70 4,438.50 3,065.10
2017-06-30 23,204.00 4,327.30 3,242.00
2017-03-31 25,574.00 4,647.40 3,233.10
2016-12-31 25,276.50 4,621.70 3,146.00
2016-09-30 25,433.00 4,580.60 3,176.60
2016-06-30 22,753.90 4,225.00 3,331.70
2016-03-31 24,822.50 4,208.70 6,715.90
2015-12-31 24,232.90 4,104.60 6,845.60
2015-09-30 23,543.40 3,544.20 8,263.20
2015-06-30 23,322.70 3,461.40 3,034.80
2015-03-31 22,600.70 3,289.50 6,204.80
2014-12-31 22,055.80 3,228.20 6,235.70
2014-09-30 21,321.40 3,087.30 6,413.90
2014-06-30 20,485.80 3,020.20 6,074.00
2014-03-31 19,885.70 2,639.90 5,737.50
2013-12-31 19,048.50 2,353.20 5,584.90
2013-09-30 18,048.30 2,127.40 5,466.30
2013-06-30 16,860.50 2,032.20 5,413.70
2013-03-31 15,776.85 1,866.20 5,018.57
2012-12-31 14,872.55 1,865.80 4,799.07
2012-09-30 13,680.70 1,837.80 3,103.20
2012-06-30 12,976.40 1,812.90 4,386.90

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Procter & Gamble Hygiene and Health Care made outstanding use of shareholders’ funds last year (Return on Equity greater than 40%).
  • Procter & Gamble Hygiene and Health Care used its assets more efficiently than the IN Personal Products industry average last year based on Return on Assets.
  • Procter & Gamble Hygiene and Health Care has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Procter & Gamble Hygiene and Health Care's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Personal Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Procter & Gamble Hygiene and Health Care has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

500459 Health

 How is Procter & Gamble Hygiene and Health Care's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Procter & Gamble Hygiene and Health Care's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Procter & Gamble Hygiene and Health Care is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Procter & Gamble Hygiene and Health Care's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Procter & Gamble Hygiene and Health Care's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Procter & Gamble Hygiene and Health Care has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Procter & Gamble Hygiene and Health Care Company Filings, last reported 3 months ago.

BSE:500459 Past Debt and Equity Data
Date (Data in INR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 9,182.60 0.00 6,410.40
2018-09-30 8,055.00 20.90 3,938.40
2018-06-30 8,055.00 20.90 3,938.40
2018-03-31 6,661.20 0.00 2,860.30
2017-12-31 6,661.20 0.00 2,860.30
2017-09-30 5,261.20 20.90 1,034.50
2017-06-30 5,261.20 20.90 1,034.50
2017-03-31 17,665.50 0.00 12,427.10
2016-12-31 17,665.50 0.00 12,427.10
2016-09-30 15,112.10 0.00 10,748.70
2016-06-30 16,517.80 18.90 10,671.80
2016-03-31 14,451.60 0.00 10,017.70
2015-12-31 14,451.60 0.00 10,017.70
2015-09-30 12,286.80 0.00 6,185.80
2015-06-30 12,286.80 0.00 6,185.80
2015-03-31 11,528.80 0.00 4,245.10
2014-12-31 11,528.80 0.00 4,245.10
2014-09-30 10,029.00 0.00 2,690.80
2014-06-30 10,029.00 0.00 2,690.80
2014-03-31 9,366.80 0.00 1,361.20
2013-12-31 9,366.80 0.00 1,361.20
2013-09-30 8,053.20 22.30 1,660.30
2013-06-30 8,053.20 22.30 1,660.30
2013-03-31 7,963.00 0.00 1,807.90
2012-12-31 7,963.00 0.00 1,807.90
2012-09-30 6,970.40 0.00 1,823.70
2012-06-30 6,970.40 64.40 1,823.70
  • Procter & Gamble Hygiene and Health Care has no debt.
  • Procter & Gamble Hygiene and Health Care had no debt 5 years ago.
  • Procter & Gamble Hygiene and Health Care has no debt, it does not need to be covered by operating cash flow.
  • Procter & Gamble Hygiene and Health Care has no debt, therefore coverage of interest payments is not a concern.
X
Financial health checks
We assess Procter & Gamble Hygiene and Health Care's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Procter & Gamble Hygiene and Health Care has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

500459 Dividends

 What is Procter & Gamble Hygiene and Health Care's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.37%
Current annual income from Procter & Gamble Hygiene and Health Care dividends. Estimated to be 1.1% next year.
If you bought ₹2,000 of Procter & Gamble Hygiene and Health Care shares you are expected to receive ₹7 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Procter & Gamble Hygiene and Health Care's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.5%).
  • Procter & Gamble Hygiene and Health Care's dividend is below the markets top 25% of dividend payers in India (1.94%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BSE:500459 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
India Personal Products Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 1%
India Market Average Dividend Yield Market Cap Weighted Average of 1400 Stocks 1.4%
India Minimum Threshold Dividend Yield 10th Percentile 0.3%
India Bottom 25% Dividend Yield 25th Percentile 0.5%
India Top 25% Dividend Yield 75th Percentile 1.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BSE:500459 Future Dividends Estimate Data
Date (Data in ₹) Dividend per Share (annual) Avg. No. Analysts
2021-06-30 145.00 1.00
2020-06-30 115.40 1.00
2019-06-30 92.90 1.00
BSE:500459 Past Annualized Dividends Data
Date (Data in ₹) Dividend per share (annual) Avg. Yield (%)
2019-02-07 40.000 0.384
2018-08-23 40.000 0.414
2017-08-23 27.000 0.290
2016-08-26 36.000 0.499
2015-08-28 30.250 0.498
2014-08-26 27.500 0.448
2014-08-13 27.500 0.530
2013-08-14 25.000 0.782
2012-11-22 22.500 0.848
2012-08-24 22.500 0.921
2011-11-24 22.500 1.102
2010-08-19 22.500 1.179
2010-08-18 22.500 1.009
2009-06-30 22.500 1.428
2009-04-20 20.000 2.357

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Procter & Gamble Hygiene and Health Care's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (1.4x coverage).
X
Income/ dividend checks
We assess Procter & Gamble Hygiene and Health Care's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Procter & Gamble Hygiene and Health Care afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Procter & Gamble Hygiene and Health Care has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

500459 Management

 What is the CEO of Procter & Gamble Hygiene and Health Care's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Madhusudan Gopalan
AGE 41
TENURE AS CEO 0.8 years
CEO Bio

Mr. Madhusudan Gopalan, has been Managing Director at Gillette India Ltd since July 01, 2018. He has been the Managing Director and Director of Procter & Gamble Hygiene and Health Care Limited since July 1, 2018. Mr. Gopalan joined P&G India in 1999 in sales and later worked in the Cincinnati headquarters of the consumer goods company. He has more than 18 years of experience working for P&G across business units and diverse geographies like India, US and ASEAN countries. While based in Cincinnati, he worked with P&G's business team that focuses on it's largest retail partner, Walmart. He later was Head of market, strategy and planning in India. He was in charge of P&G's Indonesia business. He is an alumnus of lIM Calcutta.

CEO Compensation
  • Insufficient data for Madhusudan to compare compensation growth.
  • Insufficient data for Madhusudan to establish whether their remuneration is reasonable compared to companies of similar size in India.
Management Team Tenure

Average tenure of the Procter & Gamble Hygiene and Health Care management team in years:

1.8
Average Tenure
  • The average tenure for the Procter & Gamble Hygiene and Health Care management team is less than 2 years, this suggests a new team.
Management Team

Madhusudan Gopalan

TITLE
MD & Director
AGE
41
TENURE
0.8 yrs

Prashant Bhatnagar

TITLE
Chief Financial Officer
COMPENSATION
₹5M
TENURE
4.5 yrs

John Chevalier

TITLE
Chief Investor Relations Officer
TENURE
2.9 yrs

Flavia Machado

TITLE
Company Secretary & Compliance Officer
TENURE
0.6 yrs
Board of Directors Tenure

Average tenure and age of the Procter & Gamble Hygiene and Health Care board of directors in years:

4.2
Average Tenure
49
Average Age
  • The tenure for the Procter & Gamble Hygiene and Health Care board of directors is about average.
Board of Directors

Rajendra Shah

TITLE
Chairman
COMPENSATION
₹1M
AGE
87
TENURE
1.3 yrs

Madhusudan Gopalan

TITLE
MD & Director
AGE
41
TENURE
0.8 yrs

Anil Gupta

TITLE
Independent Director
COMPENSATION
₹1M
AGE
72
TENURE
10.1 yrs

Pramod Agarwal

TITLE
Non-Executive Director
AGE
56
TENURE
3.9 yrs

Shailyamanyu Rathore

TITLE
Non-Executive Director
AGE
42
TENURE
5.1 yrs

Bansi Mehta

TITLE
Non-Executive Independent Director
COMPENSATION
₹1M
AGE
83
TENURE
13.5 yrs

Sonali Dhawan

TITLE
Non-Executive Director
AGE
42
TENURE
4.9 yrs

Karthik Natarajan

TITLE
Non-Executive Director
AGE
41
TENURE
4.5 yrs

Gagan Sawhney

TITLE
Non-Executive Director
TENURE
0.3 yrs

Meena Ganesh

TITLE
Additional Non-Executive Independent Director
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₹) Value (₹)
X
Management checks
We assess Procter & Gamble Hygiene and Health Care's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Procter & Gamble Hygiene and Health Care has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

500459 News

Simply Wall St News

Why Procter & Gamble Hygiene and Health Care Limited (BOM:500459) Is A Buy When Markets Go Down

Procter & Gamble Hygiene and Health Care Limited is a financially healthy and robust stock with a proven track record of outperformance. … We all know Procter & Gamble Hygiene and Health Care, and having this large-cap to cushion your portfolio during a volatile period in the stock market isn't a bad idea. … Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast moving consumer goods in the femcare and healthcare businesses in India

Simply Wall St -

500459 Company Info

Description

Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast moving consumer goods in the femcare and healthcare businesses in India. The company offers health care products, including ointment and creams, and cough drops and tablets; and hygiene products comprising feminine hygiene and other skin care hygiene products under the Vicks, Whisper, and Old Spice brand names. Procter & Gamble Hygiene and Health Care Limited sells its products through retail operations, including mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was founded in 1964 and is headquartered in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited is a subsidiary of Procter & Gamble Overseas India B.V.

Details
Name: Procter & Gamble Hygiene and Health Care Limited
500459
Exchange: BSE
Founded: 1964
₹348,008,304,582
32,460,736
Website: http://www.pg.com/en_IN
Address: Procter & Gamble Hygiene and Health Care Limited
P&G Plaza,
Cardinal Gracias Road,
Mumbai,
Maharashtra, 400099,
India
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BSE 500459 Equity Shares Mumbai Stock Exchange IN INR 05. Jan 2000
NSEI PGHH Equity Shares National Stock Exchange of India IN INR 05. Jan 2000
Number of employees
Current staff
Staff numbers
359
Procter & Gamble Hygiene and Health Care employees.
Industry
Personal Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/19 12:36
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/04/08
Last earnings filing: 2019/02/07
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.